Publication:
Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.

dc.contributor.authorSala-Vila, Aleix
dc.contributor.authorDíaz-López, Andrés
dc.contributor.authorValls-Pedret, Cinta
dc.contributor.authorCofán, Montserrat
dc.contributor.authorGarcía-Layana, Alfredo
dc.contributor.authorLamuela-Raventós, Rosa-María
dc.contributor.authorCastañer, Olga
dc.contributor.authorZanon-Moreno, Vicente
dc.contributor.authorMartinez-Gonzalez, Miguel A
dc.contributor.authorToledo, Estefanía
dc.contributor.authorBasora, Josep
dc.contributor.authorSalas-Salvadó, Jordi
dc.contributor.authorCorella, Dolores
dc.contributor.authorGómez-Gracia, Enrique
dc.contributor.authorFiol, Miquel
dc.contributor.authorEstruch, Ramón
dc.contributor.authorLapetra, José
dc.contributor.authorFitó, Montserrat
dc.contributor.authorArós, Fernando
dc.contributor.authorSerra-Majem, Luis
dc.contributor.authorPintó, Xavier
dc.contributor.authorRos, Emilio
dc.contributor.authorPrevención con Dieta Mediterránea (PREDIMED) Investigators
dc.date.accessioned2023-01-25T08:35:37Z
dc.date.available2023-01-25T08:35:37Z
dc.date.issued2016
dc.description.abstractDiabetic retinopathy (DR) is a devastating complication of individuals with type 2 diabetes mellitus. The retina is rich in long-chain ω-3 polyunsaturated fatty acids (LCω3PUFAs), which are substrate for oxylipins with anti-inflammatory and antiangiogenic properties. Experimental models support dietary LCω3PUFA protection against DR, but clinical data are lacking. To determine whether LCω3PUFA intake relates to a decreased incidence of sight-threatening DR in individuals with type 2 diabetes older than 55 years. In late 2015, we conceived a prospective study within the randomized clinical trial Prevención con Dieta Mediterránea (PREDIMED), testing Mediterranean diets supplemented with extra virgin olive oil or nuts vs a control diet for primary cardiovascular prevention. The trial was conducted in primary health care centers in Spain. From 2003 to 2009, 3614 individuals aged 55 to 80 years with a previous diagnosis of type 2 diabetes were recruited. Full data were available for 3482 participants (48% men; mean age 67 years). Meeting the dietary LCω3PUFA recommendation of at least 500 mg/d for primary cardiovascular prevention, as assessed by a validated food-frequency questionnaire. The main outcome was incident DR requiring laser photocoagulation, vitrectomy, and/or antiangiogenic therapy confirmed by an external adjudication committee. Of the 3482 participants, 48% were men and the mean age was 67 years. A total of 2611 participants (75%) met target LCω3PUFA recommendation. During a median follow-up of 6 years, we documented 69 new events. After adjusting for age, sex, intervention group, and lifestyle and clinical variables, participants meeting the LCω3PUFA recommendation at baseline (≥500 mg/d) compared with those not fulfilling this recommendation ( In middle-aged and older individuals with type 2 diabetes, intake of at least 500 mg/d of dietary LCω3PUFA, easily achievable with 2 weekly servings of oily fish, is associated with a decreased risk of sight-threatening DR. Our results concur with findings from experimental models and the current model of DR pathogenesis. clinicaltrials.gov Identifier: http://www.controlled-trials.com/ISRCTN35739639.
dc.identifier.doi10.1001/jamaophthalmol.2016.2906
dc.identifier.essn2168-6173
dc.identifier.pmid27541690
dc.identifier.unpaywallURLhttps://jamanetwork.com/journals/jamaophthalmology/articlepdf/2543478/eoi160065.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10370
dc.issue.number10
dc.journal.titleJAMA ophthalmology
dc.journal.titleabbreviationJAMA Ophthalmol
dc.language.isoen
dc.organizationSevilla
dc.page.number1142-1149
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeRandomized Controlled Trial
dc.rights.accessRightsopen access
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshDiabetic Retinopathy
dc.subject.meshDietary Supplements
dc.subject.meshFatty Acids, Omega-3
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshProspective Studies
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshSeafood
dc.subject.meshSpain
dc.subject.meshTime Factors
dc.subject.meshTreatment Outcome
dc.titleDietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number134
dspace.entity.typePublication

Files